Cytochrome P450 3A4 is an important mediator of drug catabolism that can be
regulated by the steroid and xenobiotic receptor (SXR). We show here that
SXR also regulates drug efflux by activating expression of the gene MDR1, w
hich encodes the protein P-glycoprotein (ABCB1). Paclitaxel (Taxol), a comm
only used chemotherapeutic agent, activated SXR and enhanced P-glycoprotein
-mediated drug clearance. In contrast, docetaxel (Taxotere), a closely rela
ted antineoplastic agent, did not activate SXR and displayed superior pharm
acokinetic properties. Docetaxel's silent properties reflect its inability
to displace transcriptional corepressors from SXR. We also found that ET-74
3, a potent antineoplastic agent, suppressed MDR1 transcription by acting a
s an inhibitor of SXR. These findings demonstrate how the molecular activit
ies of SXR can be manipulated to control drug clearance.